Bacterial cultures, rapid strep test, and antibiotic treatment in infected hard-to-heal ulcers in primary care

Scandinavian Journal of Primary Health Care

Volumn 30, Issue 4, 2012, Pages 254-258

  Öien, Rut F ^a   Åkesson, Nina ^a  

^a Blekinge Wound Healing Center   (Sweden)

Author keywords

Bacteriological spectrum; Continuity of medical care; Group A streptococci (GAS); Group G streptococci (GGS); Pseudomonas aeruginosa; Staphylococcus aureus; Ulcer infection

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PATIENT CARE; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; STANDARD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME; ULCER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; CONTINUITY OF PATIENT CARE; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; TREATMENT OUTCOME; ULCER;

EID: 84870212519     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.3109/02813432.2012.711192     Document Type: Article

References (26)

1. Öien RF, Håkansson A, Ovhed I, Hansen BU. Wound management for 287 patients with chronic leg ulcers demands 12 full-time nurses. Leg ulcer epidemiology and care in a well-defined population in Southern Sweden. Scand J Prim Health Care 2000;18:220-5. (Pubitemid 32049951)
2. Wiström J, Lindholm C, Melhus A, Lundgren C, Hansson C. Infections and treatment in chronic leg ulcers: The use of antibiotics is too excessive, restrictive prescription is recom-mended [in Swedish]. Lakartidningen. 1999;6:96:42-6.
3. André M, Eriksson M, Odenholt I. Treatment of patients with skin and soft tissue infections: Results from the STRAMA survey of diagnoses and prescriptions among general practi-tioners. Lakartidningen 2006;103:3165-7. [in Swedish].
4. European Wound Management Association (EWMA) Posi-tion document: Management of wound infection. London: MEP; 2006.
5. Cutting KF, White RJ. Criteria for identifying wound infec-tion- revisited. Ostomy Wound Manage 2005;51:28-34.
6. Petursson P. GPs'reasons for "non-pharmacological" prescribing of antibiotics: A phenomenological study. Scand J Prim Health Care 2005;23:120-5. (Pubitemid 40904668)
7. Lindholm C, Bjellerup M, Christensen OB, Zederfeldt B. Quality of life in chronic leg ulcer patients: An assessment according to the Nottingham Health Profile. Acta Derm Venereol 1993;73:440-3. (Pubitemid 23351344)
8. Anon. Evidence-based prescribing of advanced wound dress-ings for chronic wounds in primary care. MeRec Bulletin 2010;1:1-7.
9. Hansson C, Hoborn J, Möller A, Swanbeck G. The micro-bial flora in venous leg ulcers without clinical signs of infec-tion: Repeated culture using a validated standardised microbiological technique. Acta Derm Venereol 1995;75:24-30.
10. Brook I, Frazier EH. Aerobic and anaerobic microbiology of chronic venous ulcers. Int J Dermatol 1998;37:426-8. (Pubitemid 28284869)
11. Körber A, Schmid EN, Buer J, Klode J, Schadendorf D, Dissemond J. Bacterial colonization of chronic leg ulcers: Current results compared with data 5 years ago in a special-ized dermatology department. J Eur Acad Dermatol Vener-eol. 2010;24:1017-25. Epub 2010 Mar 4.
12. Recommendation from the Medical Products Agency -Sweden. Farmakologisk behandling av bakteriella hud- och mjukdelsinfektioner- ny rekommendation [Pharmacological treatment of bacterial skin and soft tissue infections]. 2009;20(5). Available from: http://www.lakemedelsverket.se/ [in Swedish].
13. Eriksson B, Jorup-Rönström C, Karkkonen K, Sjöblom AC, Holm SE. Erysipelas: Clinical and bacteriologic spectrum and serological aspects. Clin Infec Dis 1996;23:1091-8. (Pubitemid 26367499)
14. Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology 2007;215:118-22. (Pubitemid 47230719)
15. Öien RF. RUT (Register of Ulcer Treatment)-a winning concept for both patients and the health care sector. EWMA J 2009;9:41-4.
16. Llor C, Hernández S, Sierra N, Moragas A, Hernández M, Bayona C. Association between use of rapid antigen detec-tion tests and adherence to antibiotics in suspected strepto-coccal pharyngitis. Scand J Prim Health Care 2010;28:12-17.
17. Moffatt CJ, Franks PJ, Oldroyd M, Bosanquet N, Brown P, Greenhalgh RM, et al. Community clinics for leg ulcers and impact on healing. BMJ 1992;305:1389-92.
18. Forssgren A, Fransson I, Nelzén O. Leg ulcer point preva-lence can be decreased by broad-scale intervention: A follow-up cross-sectional study of a defined geographical population. Acta Derm Venereol 2008;88:252-6. (Pubitemid 351743868)
19. Corey GR, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T. CANVAS 1: The first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin struc-ture infections. J Antimicrob Chemother 2010; 65(Suppl 4): iv41-51. doi:10.1093/jac/dkq254
20. Cohen-Poradosu R, Jaffe J, Lavi D, Grisariu-Greenzaid S, Nir-Paz R, Valinsky L, et al. Group G streptococcal bacter-emia in Jerusalem. Emerg Infect Dis 2004;10:1455-60.
21. Skogberg K, Simonen H, Renkonen O-V, Valtonen VV. Beta-haemolytic group A, B, C and G streptococcal sep-ticaemia: A clinical study. Scand J Infect Dis 1988;20:119-25.
22. Dobie D, Gray J. Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child 2004;89:74-7. (Pubitemid 38122019)
23. Bangert S, Levy M, Hebert AA. Bacterial resistance and impetigo treatment trends: A review. Pediatr Dermatol 2012;29:243-48.
24. Gjelstad S, Dalen I, Lindbaek M. GPs'antibiotic prescription patterns for respiratory tract infections: Still room for improvement. Scand J Prim Health Care 2009;27:208-15.
25. Patel M. Community-associated methicillin-resistant Staphylococcus aureus infections: Epidemiology, recognition and management. Drugs 2009;69:693-716. doi: 10.2165/ 00003495 -200969060-00004.
26. Broyles LN, Van Beneden C, Beall B, Facklam R, Shewmaker PL, Malpiedi P. et al. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009;48:706-12.